Activities - Tissue Engineering

The Tissue Engineering SIG is active in:

  • suggesting, organizing, and implementing symposia, workshops, tutorials, and general scientific sessions at the SFB Annual Meeting and other SFB-sponsored meetings
  • providing networking opportunities for researchers who work at the interface between the fields of biomaterials and tissue engineering
  • promoting interactions between academia, clinicians, government, and industry in areas that impact tissue engineering
  • enhancing education in the area of biomaterials and tissue engineering, by contributing articles to relevant publications and organizing educational sessions at meetings
  • encouraging members to pursue the highest quality science and to develop the next generation of technologies to bring tissue engineering into wider clinical use
  • collaborating with other SIGs to further the goals of the Society as a whole, and to promote advances in biomedical materials research in a broad range of applications

Following is a list of the Tissue Engineering SIG-sponsored sessions that were held at the SFB 2013 Annual Meeting:


Biologically Inspired Biomaterials Approaches for Cancer Research
Organizers Claudia Fischbach, PhD, Cornell University and Hyung Joon Kong, PhD, University of Illinois at Urban – Champaign
Microenvironmental conditions play an important role in the development, progression, and therapy of cancer, and biomaterials may be invaluable in the generation of more appropriate culture models that will help to identify the underlying mechanisms and effects. This session will focus on the design and utilization of biologically inspired model systems to gain a better understanding of the pathology and treatment of cancer. It will highlight biomaterials in the context of cell and tissue engineering to evaluate tumorigenesis as a function of specific cell-microenvironment interactions including but not limited to cell-cell and cell-extracellular matrix interactions and mechanical cues. Additionally, it will provide a forum to evaluate tumor-mimetic culture models as drug testing systems for industrial applications. This session will provide a communication platform for biomaterials scientists and cancer biologists interested in the development and utilization of innovative and biologically relevant culture microenvironments.

Biomaterials for Cardiac Repair
Organizer: Karen Christman, PhD, University of California San Diego

Biomaterial scaffolds have the potential to offer new therapies for a variety of cardiac repair applications including myocardial infarction, heart failure, and congenital defects. While numerous clinical trials with injected stem cells are ongoing, this approach continues to be limited by poor cell retention and survival. Biomaterial scaffolds are expected to enhance these cellular therapies by improving the structural and functional repair of the heart as well as offer acellular alternatives that encourage endogenous cell infiltration and repair. The aim of this symposium is to bring together leaders in the field of cardiac tissue engineering and biomaterials to present recent innovative approaches and discuss challenges related to both cellular and acellular approaches for repairing and regenerating the myocardium. Both patches and injectable scaffolds for treating various cardiomyopathies, such as myocardial infarction, heart failure, and congenital defects, will be covered.

Panel Discussion:

Scaffolds for Tissue Engineering: Successful Academia-Industry Collaborations
Organizer: Amol V. Janorkar, PhD, University of Mississippi Medical Center
Panelists: Barbara Boyan, PhD; Amol V. Janorkar, PhD; Anita Sawyer, MS; Anthony Ratcliffe, PhD
Tremendous research has been done in recent times to use biomaterials to guide three dimensional tissue formations both in vitro and in vivo. As this tissue engineering research progresses into more successful outcomes, interdependence and partnership between academia and industry take immense importance. Panelists will discuss their interactions with academia or industry regarding the latest developments in creating three dimensional scaffolds on an industrial scale, challenges encountered, and their solutions.

General Sessions:

Tissue Engineering I and II
Organizer: Elizabeth Cosgriff-Hernandez, PhD, Texas A&M University
Tissue engineering has emerged as a promising alternative for the reconstitution of lost or damaged organs and tissues, circumventing the complications associated with traditional transplants. This session will review current state of the art in the development and characterization of tissue engineering constructs. Specific areas to be covered are the use of appropriate materials (synthetic and natural) with cells (either native or from a donor source) and/or biological response modifiers (e.g., growth factors, cytokines and other recombinant products) to replace tissue and organ functions.

Back to TE SIG

SFB News

The Biomaterials Forum Third Quarter 2021 issue is now available online!